Inventor · disambiguated record
Eduardo Dunayevich
Also filed as: DUNAYEVICH EDUARDO
8 granted patents·11 pending applications·99 citations·filing 2011–2022
88Inventor score
Top patents by PatentIndex Score
19 records- 0197US11406623B2Methods of treating tuberous sclerosis complex with cannabidiol and everolimusGW RES LTD·Filed 2021·Granted Aug 9, 2022·24 cites·25 claims
- 0297US11160795B2Methods of treating tuberous sclerosis complex with cannabidiol and everolimusGW RES LTD·Filed 2021·Granted Nov 2, 2021·38 cites·29 claims
- 0396US12102619B2Methods of treating tuberous sclerosis complex with cannabidiol and everolimusJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2022·Granted Oct 1, 2024·7 cites·24 claims
- 0490US11033543B2Methods of providing weight loss therapy in patients with major depressionNALPROPION PHARMACEUTICALS LLC·Filed 2019·Granted Jun 15, 2021·3 cites·19 claims
- 0590US10259877B2Methods for treating or preventing migraine headacheAMGEN INC·Filed 2016·Granted Apr 16, 2019·8 cites·58 claims
- 0686US11466090B2Methods for treating or preventing migraine headacheAMGEN INC·Filed 2019·Granted Oct 11, 2022·3 cites·38 claims
- 0786US9248123B2Methods of providing weight loss therapy in patients with major depressionDUNAYEVICH EDUARDO·Filed 2011·Granted Feb 2, 2016·12 cites·18 claims
- 0885US10322121B2Methods of providing weight loss therapy in patients with major depressionOREXIGEN THERAPEUTICS INC·Filed 2016·Granted Jun 18, 2019·4 cites·17 claims
- 0974US2022233520A1Increasing Drug Bioavailability In Naltrexone TherapyNALPROPION PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 1073US2022105087A1Increasing Drug Bioavailability In Naltrexone TherapyNALPROPION PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1171US2022088007A1Increasing Drug Bioavailability In Naltrexone TherapyNALPROPION PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1271US2021299119A1Methods Of Providing Weight Loss Therapy In Patients With Major DepressionNALPROPION PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1371US2019358222A1Increasing Drug Bioavailability In Naltrexone TherapyNALPROPION PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1470US2023020514A1Methods for treating or preventing migraine headacheAMGEN INC·Filed 2022·Application pending·0 cites
- 1559US2021283126A1Methods For Reducing Binge Or Compulsive EatingNALPROPION PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1651US2022257529A1Use of cannabidiol in the treatment of epileptic spasmsGW RES LTD·Filed 2020·Application pending·0 cites
- 1750US2024408086A1Use of luvadaxistat for the treatment of cognitive impairmentTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1839US2013252995A1Methods for reducing binge or compulsive eatingDUNAYEVICH EDUARDO·Filed 2011·Application pending·0 cites
- 1938US2013245056A1Increasing drug bioavailability in naltrexone therapyFLANAGAN SHAWN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eduardo Dunayevich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →